Portal hypertension is a common complication of cirrhosis, contributing to significant morbidity and mortality in patients with chronic liver disease. Non-invasive methods for diagnosing portal hypertension have emerged as valuable tools for risk stratification, treatment monitoring and prognostication in patients with Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV)-related cirrhosis. This review provides a comprehensive overview of non-invasive methods for portal hypertension diagnosis, including imaging techniques, serum biomarkers and transient elastography. The utility, accuracy and limitations of non-invasive diagnostic modalities in HBV-and HCV-related cirrhosis are discussed, with a focus on their clinical implications and future directions in liver disease management.
HTML PDFShare this article
Journal of Hypertension: Open Access received 614 citations as per Google Scholar report
